Skip to content

Hamilton Lane HLNE Stock issued for employee stock purchase plan

Stock issued for employee stock purchase plan at other companies

Zymeworks logo
ZymeworksZYME
$649K-10.4%
Healthcare Services Group logo
Healthcare Services GroupHCSG
$1.68M+64.5%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$1.11M-8.5%
HWK
HawkinsHWKN
$1.61M+24.1%
SkyWest logo
SkyWestSKYW
$1.31M+1.5%
SPS Commerce logo
SPS CommerceSPSC
$520K+26.5%

Other financials

Income statement

See full
Revenue$193.6M-2.2%
Net income$66.2M+31.0%
EPS (diluted)$1.48+9.4%

Balance sheet

See full
Cash & equivalents$348.0M+6.3%
Total debt$356.5M-3.2%
Total equity$915.2M+27.6%
Total assets$2.3B+36.4%

Cash flow

See full
Operating cash flow$103.0M+162%
CapEx$1.7M-49.3%
Free cash flow$101.2M+182%

Valuation

See full
Market cap$3.3B-32.2%

Profitability

See full
Net margin32.8%+2.3pp
FCF margin55.2%+14.7pp

Returns & leverage

See full
Return on equity30.5%-4.5pp
Debt / equity0.4×-0.1×

Where this comes from

Reported directly by Hamilton Lane in its filing.

Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan.

The official record: Hamilton Lane’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Hamilton Lane's stock issued for employee stock purchase plan.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Hamilton Lane's stock issued for employee stock purchase plan?
Hamilton Lane (HLNE) reported stock issued for employee stock purchase plan of $826K in Q4 2025.